首页> Clinical and experimental dermatology> Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study.

Long-term effectiveness, safety and prognostic factors of response to treatment with bimekizumab in psoriasis patients: results from a real-world multicentre study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alexander,Katoulis

第一单位： 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

作者： Alexander,Katoulis ^[1] ; Evangelia,Papadavid ^[1] ; Ioannis-Alexios,Koumprentziotis ^[2] ; Natalia,Rompoti ^[2] ; Irene,Stefanaki ^[2] ; Pantelis,Panagakis ^[3] ; Sofia,Theotokoglou ^[1] ; Charitomeni,Vavouli ^[2] ; Kyriaki,Lampadaki ^[1] ; Marina,Papoutsaki ^[2] ; Konstantinos,Theodoropoulos ^[1] ; Maria,Politou ^[2] ; Antonios,Kanelleas ^[1] ; Angeliki,Befon ^[3] ; Eleni,Lazou ^[3] ; Fiori,Kousta ^[3] ; Maria,Tzaki ^[1] ; Vasiliki,Chasapi ^[3] ; Alexander,Stratigos ^[2] ; Electra,Nicolaidou ^[2]

作者单位： 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. ^[1] 1st Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece. ^[2] State Department of Dermatology and Venereology NHS, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece. ^[3]

DOI 10.1093/ced/llaf492

PMID 41205819

发布时间 2025-11-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交